GSK-1071306

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H21N7O2S
Molecular Weight	423.491
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1N=C2C=C(NC3=CC=NC(NC4=CC=C(C)C(=C4)S(N)(=O)=O)=N3)C=CC2=C1C

InChI

InChIKey=XWOGXAVHJKKNPO-UHFFFAOYSA-N

InChI=1S/C20H21N7O2S/c1-12-4-5-15(11-18(12)30(21,28)29)24-20-22-9-8-19(25-20)23-14-6-7-16-13(2)27(3)26-17(16)10-14/h4-11H,1-3H3,(H2,21,28,29)(H2,22,23,24,25)

HIDE SMILES / InChI

Molecular Formula	C20H21N7O2S
Molecular Weight	423.491
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 08:09:36 GMT 2023` Edited by `admin` on `Sat Dec 16 08:09:36 GMT 2023`
Record UNII	Z51V93OIDV
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GSK-1071306

Common Name

English

PAZOPANIB METABOLITE M27

Common Name

English

BENZENESULFONAMIDE, 5-((4-((2,3-DIMETHYL-2H-INDAZOL-6-YL)AMINO)-2-PYRIMIDINYL)AMINO)-2-METHYL-

Systematic Name

English

GSK1071306

Code

English

Code System Code Type Description

CAS

1252927-47-1

Created by admin on Sat Dec 16 08:09:36 GMT 2023 , Edited by admin on Sat Dec 16 08:09:36 GMT 2023

PRIMARY

FDA UNII

Z51V93OIDV

Created by admin on Sat Dec 16 08:09:36 GMT 2023 , Edited by admin on Sat Dec 16 08:09:36 GMT 2023

PRIMARY

CAS

1414375-48-6

Created by admin on Sat Dec 16 08:09:36 GMT 2023 , Edited by admin on Sat Dec 16 08:09:36 GMT 2023

NO STRUCTURE GIVEN

PUBCHEM

68319455

Created by admin on Sat Dec 16 08:09:36 GMT 2023 , Edited by admin on Sat Dec 16 08:09:36 GMT 2023

PRIMARY

Related Record Type Details


					7RN5DR86CK

PAZOPANIB

PARENT -> METABOLITE INACTIVE

Comments:

Four pazopanib metabolites (GSK1268992, GSK1268997, GSK1071306, and GW700201) have been identified. Only one of these metabolites (GSK1268997) has been shown to inhibit the proliferation of VEGF-stimulated human umbilical vein endothelial cells with potency similar to pazopanib.